Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ceftazidime and Avibactam Sodium for Injection

Approval Number

国药准字H20234289

Company南京力博维制药有限公司

Registration Date

October 12, 2023

Drug Information

Generic Name

注射用头孢他啶阿维巴坦钠

Dosage Form

注射剂

Strength

2.5g(C₂₂H₂₂N₆O₇S₂ 2.0g与C₇H₁₁N₃O₆S 0.5g)

Drug Type

化学药品

Registration Date

October 12, 2023

Company Information

Applicant Company

Company Name南京力博维制药有限公司

Company Address

南京市江北新区长芦街道崇福路310号

Manufacturing Company

Company Name南京优科制药有限公司

Company Address

南京经济技术开发区恒竞路28号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用头孢他啶阿维巴坦钠 - NMPA 批准文号 | MedPath